Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis

Article:

Geier et al.: A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States.
Translational Neurodegeneration 2013 2:25.

The researchers looked at the risk of autism among children who received mercury-containing DTaP (acellular diphtheria/tetanus/pertussis) and hepatitis b shots. They found a significantly increased risk for the incidence of ASD reported following the mercury-containing DTaP vaccine in comparison to the mercury-free DTaP vaccine. In addition, they found children diagnosed with an ASD were significantly more likely than controls to have received a mercury-containing hepatitis B vaccine administered within the first, second, and sixth month of life.

Read the whole study here:

http://www.biomedcentral.com/content/pdf/2047-9158-2-25.pdf